ArticleBMC surgery2026
The role of biomarkers in predicting mortality in peptic ulcer perforation.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeptic ulcer perforation remains a life-threatening surgical emergency associated with considerable postoperative mortality. Identifying reliable preoperative predictors is crucial for risk stratification. In this study, we aimed to investigate the predictive value of C-reactive protein, albumin/creatinine ratio, defect size, and selected demographic variables for 30-day mortality following surgical treatment of peptic ulcer perforation.
methodsA retrospective analysis was conducted on 154 patients who underwent emergency surgery for peptic ulcer perforation. The association between 30-day postoperative mortality and C-reactive protein, albumin/creatinine ratio, defect size, as well as selected demographic variables was evaluated. Univariate and multivariate logistic regression analyses were performed. ROC analysis was used to determine optimal cutoff values. p < 0.05 was considered statistically significant.
resultsThe mean age of the patients was 56. 102 (66.2%) of the patients were male. The 30-day mortality rate in the study cohort was 16.9%. A CRP level greater than 88 mg/L (p < 0,001) and an albumin/creatinine ratio below 3.37 (p < 0.001) were identified as independent predictors of mortality. While a defect size greater than 5 mm was significant in univariate analysis, it did not retain significance in the multivariate model.
conclusionCRP and the albumin/creatinine ratio are easily accessible biomarkers that may support perioperative risk stratification in patients undergoing surgery for perforated peptic ulcer. Defect size alone may be insufficient to reliably reflect prognosis when systemic inflammatory markers are taken into account.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.